-
Noise-reduction techniques for 1H-FID-MRSI at 14.1T: Monte-Carlo validation & in vivo application
Authors:
Brayan Alves,
Dunja Simicic,
Jessie Mosso,
Thanh Phong Lê,
Guillaume Briand,
Wolfgang Bogner,
Bernard Lanz,
Bernhard Strasser,
Antoine Klauser,
Cristina Cudalbu
Abstract:
Proton magnetic resonance spectroscopic imaging (1H-MRSI) is a powerful tool that enables the multidimensional non-invasive mapping of the neurochemical profile at high-resolution over the entire brain. The constant demand for higher spatial resolution in 1H-MRSI led to increased interest in post-processing-based denoising methods aimed at reducing noise variance. The aim of the present study was…
▽ More
Proton magnetic resonance spectroscopic imaging (1H-MRSI) is a powerful tool that enables the multidimensional non-invasive mapping of the neurochemical profile at high-resolution over the entire brain. The constant demand for higher spatial resolution in 1H-MRSI led to increased interest in post-processing-based denoising methods aimed at reducing noise variance. The aim of the present study was to implement two noise-reduction techniques, the Marchenko-Pastur principal component analysis (MP-PCA) based denoising and the low-rank total generalized variation (LR-TGV) reconstruction, and to test their potential and impact on preclinical 14.1T fast in vivo 1H-FID-MRSI datasets. Since there is no known ground truth for in vivo metabolite maps, additional evaluations of the performance of both noise-reduction strategies were conducted using Monte-Carlo simulations. Results showed that both denoising techniques increased the apparent signal-to-noise ratio SNR while preserving noise properties in each spectrum for both in vivo and Monte-Carlo datasets. Relative metabolite concentrations were not significantly altered by either methods and brain regional differences were preserved in both synthetic and in vivo datasets. Increased precision of metabolite estimates was observed for the two methods, with inconsistencies noted on lower concentrated metabolites. Our study provided a framework on how to evaluate the performance of MP-PCA and LR-TGV methods for preclinical 1H-FID MRSI data at 14.1T. While gains in apparent SNR and precision were observed, concentration estimations ought to be treated with care especially for low-concentrated metabolites.
△ Less
Submitted 28 March, 2024; v1 submitted 20 September, 2023;
originally announced September 2023.
-
Fast high-resolution metabolite mapping in the rat brain using 1H-FID-MRSI at 14.1T
Authors:
Dunja Simicic,
Brayan Alves,
Jessie Mosso,
Guillaume Briand,
Thanh Phong Lê,
Ruud B. van Heeswijk,
Jana Starčuková,
Bernard Lanz,
Antoine Klauser,
Bernhard Strasser,
Wolfgang Bogner,
Cristina Cudalbu
Abstract:
Magnetic resonance spectroscopic imaging (MRSI) enables the simultaneous non-invasive acquisition of MR spectra from multiple spatial locations inside the brain. While 1H-MRSI is increasingly used in the human brain, it is not yet widely applied in the preclinical settings, mostly because of difficulties specifically related to very small nominal voxel size in the rodent brain and low concentratio…
▽ More
Magnetic resonance spectroscopic imaging (MRSI) enables the simultaneous non-invasive acquisition of MR spectra from multiple spatial locations inside the brain. While 1H-MRSI is increasingly used in the human brain, it is not yet widely applied in the preclinical settings, mostly because of difficulties specifically related to very small nominal voxel size in the rodent brain and low concentration of brain metabolites, resulting in low signal-to-noise ratio SNR.
In this context, we implemented a free induction decay 1H-MRSI sequence (1H-FID-MRSI) in the rat brain at 14.1T. We combined the advantages of 1H-FID-MRSI with the ultra-high magnetic field to achieve higher SNR, coverage and spatial resolution in the rodent brain, and developed a custom dedicated processing pipeline with a graphical user interface: MRS4Brain toolbox.
LCModel fit, using the simulated metabolite basis-set and in-vivo measured MM, provided reliable fits for the data at acquisition delays of 1.3 and 0.94 ms. The resulting Cramér-Rao lower bounds were sufficiently low (<30%) for eight metabolites of interest, leading to highly reproducible metabolic maps. Similar spectral quality and metabolic maps were obtained between 1 and 2 averages, with slightly better contrast and brain coverage due to increased SNR in the latter case. Furthermore, the obtained metabolic maps were accurate enough to confirm the previously known brain regional distribution of some metabolites. The acquisitions proved high reproducibility over time.
We demonstrated that the increased SNR and spectral resolution at 14.1T can be translated into high spatial resolution in 1H-FID-MRSI of the rat brain in 13 minutes, using the sequence and processing pipeline described herein. High-resolution 1H-FID-MRSI at 14.1T provided reproducible and high-quality metabolic mapping of brain metabolites with significantly reduced technical limitations.
△ Less
Submitted 11 March, 2024; v1 submitted 6 July, 2023;
originally announced July 2023.
-
Diffusion-weighted MR spectroscopy: consensus, recommendations and resources from acquisition to modelling
Authors:
Clémence Ligneul,
Chloé Najac,
André Döring,
Christian Beaulieu,
Francesca Branzoli,
William T Clarke,
Cristina Cudalbu,
Guglielmo Genovese,
Saad Jbabdi,
Ileana Jelescu,
Dimitrios Karampinos,
Roland Kreis,
Henrik Lundell,
Małgorzata Marjańska,
Harald E. Möller,
Jessie Mosso,
Eloïse Mougel,
Stefan Posse,
Stefan Ruschke,
Kadir Simsek,
Filip Szczepankiewicz,
Assaf Tal,
Chantal Tax,
Georg Oeltzschner,
Marco Palombo
, et al. (2 additional authors not shown)
Abstract:
Brain cell structure and function reflect neurodevelopment, plasticity and ageing, and changes can help flag pathological processes such as neurodegeneration and neuroinflammation. Accurate and quantitative methods to non-invasively disentangle cellular structural features are needed and are a substantial focus of brain research. Diffusion-weighted MR spectroscopy (dMRS) gives access to diffusion…
▽ More
Brain cell structure and function reflect neurodevelopment, plasticity and ageing, and changes can help flag pathological processes such as neurodegeneration and neuroinflammation. Accurate and quantitative methods to non-invasively disentangle cellular structural features are needed and are a substantial focus of brain research. Diffusion-weighted MR spectroscopy (dMRS) gives access to diffusion properties of endogenous intracellular brain metabolites that are preferentially located inside specific brain cell populations. Despite its great potential, dMRS remains a challenging technique on all levels: from the data acquisition to the analysis, quantification, modelling and interpretation of results. These challenges were the motivation behind the organisation of the Lorentz Workshop on 'Best Practices and Tools for Diffusion MR Spectroscopy' held in Leiden in September 2021. During the workshop, the dMRS community established a set of recommendations to execute robust dMRS studies. This paper provides a description of the steps needed for acquiring, processing, fitting and modelling dMRS data and provides links to useful resources.
△ Less
Submitted 18 May, 2023;
originally announced May 2023.
-
Diffusion-weighted SPECIAL improves the detection of J-coupled metabolites at ultra-high magnetic field
Authors:
Jessie Mosso,
Dunja Simicic,
Bernard Lanz,
Rolf Gruetter,
Cristina Cudalbu
Abstract:
A new sequence for single-voxel diffusion-weighted 1H MRS (DWS), named DW-SPECIAL, is proposed to improve the detection and subsequent estimation of the diffusion properties of strongly J-coupled metabolites. It combines the semi-adiabatic SPECIAL sequence with a stimulated echo (STE) diffusion block. Acquisitions with DW-SPECIAL and STE-LASER, the current gold-standard for rodent DWS experiments…
▽ More
A new sequence for single-voxel diffusion-weighted 1H MRS (DWS), named DW-SPECIAL, is proposed to improve the detection and subsequent estimation of the diffusion properties of strongly J-coupled metabolites. It combines the semi-adiabatic SPECIAL sequence with a stimulated echo (STE) diffusion block. Acquisitions with DW-SPECIAL and STE-LASER, the current gold-standard for rodent DWS experiments at high fields, were performed at 14.1T on phantoms and in vivo on the rat brain. The apparent diffusion coefficient and intra-stick diffusivity (Callaghan's model) were fitted and compared between the sequences for glutamate, glutamine (Gln), myo-inositol, taurine, total N-acetylaspartate, total choline, total creatine and the macromolecules. The shorter echo time achieved with DW-SPECIAL (18 ms against 33 ms with STE-LASER) substantially limited the metabolites' signal loss caused by J-evolution. In addition, DW-SPECIAL preserved the main advantages of STE-LASER: absence of cross-terms, diffusion time during a STE and limited sensitivity to B1 inhomogeneities. In vivo, compared to STE-LASER, DW-SPECIAL yielded the same spectral quality and reduced the Cramer Rao Lower Bounds (CRLB) for J-coupled metabolites, irrespective of the b-value. DW-SPECIAL also reduced the standard deviation of the metabolites' diffusion estimates based on individual animal fitting without loss of accuracy compared to the fit on the averaged decay. We conclude that due to its reduced echo time, DW-SPECIAL can serve as an alternative to STE-LASER when strongly J-coupled metabolites like Gln are investigated, thereby extending the range of accessible metabolites in the context of DWS acquisitions.
△ Less
Submitted 15 May, 2023;
originally announced May 2023.
-
MP-PCA denoising for diffusion MRS data: promises and pitfalls
Authors:
Jessie Mosso,
Dunja Simicic,
Cristina Cudalbu,
Ileana O. Jelescu
Abstract:
Diffusion-weighted (DW) magnetic resonance spectroscopy (MRS) suffers from a lower signal to noise ratio (SNR) compared to conventional MRS owing to the addition of diffusion attenuation. This technique can therefore strongly benefit from noise reduction strategies. In the present work, the Marchenko-Pastur principal component analysis (MP-PCA) denoising is tested on Monte Carlo simulations and on…
▽ More
Diffusion-weighted (DW) magnetic resonance spectroscopy (MRS) suffers from a lower signal to noise ratio (SNR) compared to conventional MRS owing to the addition of diffusion attenuation. This technique can therefore strongly benefit from noise reduction strategies. In the present work, the Marchenko-Pastur principal component analysis (MP-PCA) denoising is tested on Monte Carlo simulations and on in vivo DW-MRS data acquired at 9.4T in the rat brain. We provide a descriptive study of the effects observed following different MP-PCA denoising strategies (denoising the entire matrix versus using a sliding window), in terms of apparent SNR, rank selection, noise correlation within and across b-values and quantification of metabolite concentrations and fitted diffusion coefficients. MP-PCA denoising yielded an increased apparent SNR, a more accurate B0 drift correction between shots, and similar estimates of metabolite concentrations and diffusivities compared to the raw data. No spectral residuals on individual shots were observed but correlations in the noise level across shells were introduced, an effect which was mitigated using a sliding window, but which should be carefully considered.
△ Less
Submitted 8 April, 2022;
originally announced April 2022.
-
PET CMR$_{glc}$ mapping and $^{1}$H MRS show altered glucose uptake and neurometabolic profiles in BDL rats
Authors:
Jessie Mosso,
Ting Yin,
Carole Poitry-Yamate,
Dunja Simicic,
Mario Lepore,
Valérie A. McLin,
Olivier Braissant,
Cristina Cudalbu,
Bernard Lanz
Abstract:
Type C hepatic encephalopathy (HE) is a complex neuropsychiatric disorder occurring as a consequence of chronic liver disease. Alterations in energy metabolism have been suggested in type C HE, but $\textit{in vivo}$ studies on this matter remain sparse and have reported conflicting results. Here, we propose a novel preclinical $^{18}$F-FDG PET methodology to compute quantitative 3D maps of the re…
▽ More
Type C hepatic encephalopathy (HE) is a complex neuropsychiatric disorder occurring as a consequence of chronic liver disease. Alterations in energy metabolism have been suggested in type C HE, but $\textit{in vivo}$ studies on this matter remain sparse and have reported conflicting results. Here, we propose a novel preclinical $^{18}$F-FDG PET methodology to compute quantitative 3D maps of the regional cerebral metabolic rate of glucose (CMR$_{glc}$) from a labelling steady-state PET image of the brain and an image-derived input function. This quantitative approach shows its strength when comparing groups of animals with divergent physiology, such as HE animals. PET CMR$_{glc}$ maps were registered to an atlas and the mean CMR$_{glc}$ from the hippocampus and the cerebellum were associated to the corresponding localized $^{1}$H MR spectroscopy acquisitions. This study provides for the first time local and quantitative information on both brain glucose uptake and neurometabolic profile alterations in a rat model of type C HE. A 2-fold lower brain glucose uptake, concomitant with an increase in brain glutamine and a decrease in the main osmolytes was observed in the hippocampus and in the cerebellum. These novel findings are an important step towards new insights into energy metabolism in the pathophysiology of HE.
△ Less
Submitted 22 December, 2021;
originally announced December 2021.